Imatinib Completed Phase 4 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00390897GlivecĀ® (Imatinib Mesylate, STI571) in Monotherapy Versus GlivecĀ®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia